Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Cell Reports
|
November 1, 2023
Insulin receptor loss impairs mammary tumorigenesis in mice
Lauren Podmore, Yekaterina Poloz, Catherine Iorio, et al.
Leukemia
|
July 16, 2020
The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma
Joseph Longo, Petr Smirnov, Zhihua Li, et al.
Cancer Research
|
March 19, 2017
Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
Nehme El-Hachem, Deena M A Gendoo, Laleh Soltan Ghoraie, et al.
F1000Research
|
September 23, 2017
Revisiting inconsistency in large pharmacogenomic studies
Zhaleh Safikhani, Petr Smirnov, Mark Freeman, et al.
Nucleic Acids Research
|
December 1, 2021
PharmacoDB 2.0: improving scalability and transparency of in vitro pharmacogenomics analysis
Nikta Feizi, Sisira Kadambat Nair, Petr Smirnov, et al.
Nature Communications
|
October 5, 2021
Orchestrating and sharing large multimodal data for transparent and reproducible research
Anthony Mammoliti, Petr Smirnov, Minoru Nakano, et al.
Bioinformatics (Oxford, England)
|
December 15, 2015
PharmacoGx: an R package for analysis of large pharmacogenomic datasets
Petr Smirnov, Zhaleh Safikhani, Nehme El-Hachem, et al.
Nature Communications
|
November 23, 2024
Multi-omic and single-cell profiling of chromothriptic medulloblastoma reveals genomic and transcriptomic consequences of genome instability
Petr Smirnov, Moritz J Przybilla, Milena Simovic-Lorenz, et al.
Nature Communications
|
January 27, 2025
Author Correction: Multi-omic and single-cell profiling of chromothriptic medulloblastoma reveals genomic and transcriptomic consequences of genome instability
Petr Smirnov, Moritz J Przybilla, Milena Simovic-Lorenz, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Cell Reports
|
November 1, 2023
Insulin receptor loss impairs mammary tumorigenesis in mice
Lauren Podmore, Yekaterina Poloz, Catherine Iorio, et al.
Leukemia
|
July 16, 2020
The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma
Joseph Longo, Petr Smirnov, Zhihua Li, et al.
Cancer Research
|
March 19, 2017
Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
Nehme El-Hachem, Deena M A Gendoo, Laleh Soltan Ghoraie, et al.
F1000Research
|
September 23, 2017
Revisiting inconsistency in large pharmacogenomic studies
Zhaleh Safikhani, Petr Smirnov, Mark Freeman, et al.
Nucleic Acids Research
|
December 1, 2021
PharmacoDB 2.0: improving scalability and transparency of in vitro pharmacogenomics analysis
Nikta Feizi, Sisira Kadambat Nair, Petr Smirnov, et al.
Nature Communications
|
October 5, 2021
Orchestrating and sharing large multimodal data for transparent and reproducible research
Anthony Mammoliti, Petr Smirnov, Minoru Nakano, et al.
Bioinformatics (Oxford, England)
|
December 15, 2015
PharmacoGx: an R package for analysis of large pharmacogenomic datasets
Petr Smirnov, Zhaleh Safikhani, Nehme El-Hachem, et al.
Nature Communications
|
November 23, 2024
Multi-omic and single-cell profiling of chromothriptic medulloblastoma reveals genomic and transcriptomic consequences of genome instability
Petr Smirnov, Moritz J Przybilla, Milena Simovic-Lorenz, et al.
Nature Communications
|
January 27, 2025
Author Correction: Multi-omic and single-cell profiling of chromothriptic medulloblastoma reveals genomic and transcriptomic consequences of genome instability
Petr Smirnov, Moritz J Przybilla, Milena Simovic-Lorenz, et al.
Page
of 3